Document Detail


A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
MedLine Citation:
PMID:  16933265     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of childhood idiopathic thrombocytopenic purpura is still an area of controversy. We reviewed the literature on anti-D treatment. Most studies used intravenous anti-D. Single doses of 50 microg/kg increased the platelet count to >or=20x10(9)/L in 70% of the children within 3 days. Intravenous anti-D seems safe in classic childhood ITP although hemolysis and occasionally renal failure may be of concern. A few studies reported intramuscularly or subcutaneously administered anti-D. Further studies on the optimal dose and route of administration of anti-D are warranted.
Authors:
Mimi Kjaersgaard; Henrik Hasle
Related Documents :
20151785 - Dosing, efficacy and safety plus the use of computerized photography for botulinum toxi...
22594565 - Single-dose pharmacokinetics and tolerability of oral delta-9-tetrahydrocannabinol in p...
22345285 - Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion...
6976235 - The primary serological response to a single dose of adsorbed tetanus toxoid, high conc...
17497635 - Lethal and sublethal responses of an aquatic insect culex quinquefasciatus (diptera: cu...
7550055 - Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural in...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pediatric blood & cancer     Volume:  47     ISSN:  1545-5009     ISO Abbreviation:  Pediatr Blood Cancer     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-08-31     Completed Date:  2006-11-28     Revised Date:  2009-01-12    
Medline Journal Info:
Nlm Unique ID:  101186624     Medline TA:  Pediatr Blood Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  717-20     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2006 Wiley-Liss, Inc.
Affiliation:
Department of Pediatrics, Aarhus University, Skejby Hospital, Denmark. mimi.kjaersgaard@ki.au.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Dose-Response Relationship, Drug
Humans
Isoantibodies / administration & dosage,  adverse effects,  therapeutic use*
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / diagnosis,  drug therapy*
Chemical
Reg. No./Substance:
0/Isoantibodies; 0/RHO(D) antibody

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rituximab treatment for symptomatic chronic ITP.
Next Document:  AMG 531: an investigational thrombopoiesis-stimulating peptibody.